Pharma’s Multi-Disciplinary Talent Push: Strategic Evolution or Hidden Risk?

Over the past few weeks, I’ve found myself in a series of long-form email exchanges with someone I’ve known for nearly my entire career in pharmaceutical marketing research. She’s a seasoned insights professional -- thoughtful, experienced, philosophical, and deeply grounded in the craft -- who is now being, in her words, “slow-motion exited” from a mid-sized pharmaceutical company.

Our conversations have been candid. At times philosophical. And increasingly, they’ve centered on a shared observation: as she explores the job market and speaks with colleagues across the industry, a clear pattern is emerging.

Pharma companies are not just hiring anymore; they’re consolidating.

Not always into a single, all-encompassing role. Sometimes it’s three functions combined. Sometimes two. I came across a LinkedIN profile just recently of someone leading both Insights and Competitive Intelligence under one remit. In other cases, it’s Insights plus Forecasting, or Analytics plus CI.

The specific combinations vary. The underlying trend does not.

Organizations are looking for multi-disciplinary professionals who can span what were once distinct functions: forecasting, analytics, insights, and competitive intelligence (CI).

On the surface, it makes sense. But it’s worth pausing to examine what may be gained, and what may be lost, in the process.

‍

Why Consolidation Is Accelerating

The broader context here is hard to ignore. Pharmaceutical companies, particularly large and mid-sized players, are navigating a period of intense pressure:

• Significant patent cliffs on the horizon
• Increasing competition and disruption from biotech and health tech entrants
• Greater scrutiny on pricing and value
• A sustained push toward operational efficiency

In that environment, role consolidation is a logical response. Fewer people covering more ground. Leaner teams. Broader mandates.

Layer in the rapid advancement of AI, tools that can accelerate analytics, synthesize research, and support elements of forecasting, and it becomes even more plausible to envision a single individual managing multiple domains.

The “Swiss Army knife” model begins to feel not just efficient, but necessary.

‍

Different Disciplines, Different Ways of Thinking

And yet, beneath this logic lies a more complicated reality. While forecasting, analytics, insights, and CI are interconnected, they are built on fundamentally different foundations, personality types, and professional backgrounds.

• Forecasting demands quantitative precision: comfort with models, assumptions, and structured processes.
• Analytics requires fluency in data, statistics, and increasingly, machine-assisted methods.
• Insights is rooted in human understanding: psychology, behavior, habits, and the ability to interpret nuance and context.
• Competitive Intelligence blends structured analysis with strategic foresight and pattern recognition.

These are not simply different tasks. They are different modes of thinking.

There are, of course, individuals who can operate across multiple domains. But expecting consistent depth across all, or even several, of these areas introduces trade-offs that are easy to underestimate.

‍

The Role of AI: Expanding Reach, Not Replacing Judgment

AI is undeniably changing how all of this work gets done. It can undeniably accelerate data processing, generate initial analyses, and even assist in synthesizing qualitative inputs. In doing so, it expands the range of what any one individual can reasonably cover.

But, as I have written here previously, AI does not eliminate the need for judgment. And judgement is rooted, to some degree, in experience and background.

AI cannot fully assess whether a forecast model is built on sound assumptions. It cannot fully interpret the emotional undercurrents in HCP or patient behavior. It cannot fully anticipate how competitive dynamics will evolve in an uncertain market. It often overlooks context.

In this sense, AI is an enabler -- but not necessarily an equalizer.

‍

The Risk of Partial Vision

The most significant risk in consolidating these roles is not simply workload. It is incomplete perspective.

When one individual is responsible for multiple disciplines, certain signals inevitably receive less attention:

• Behavioral nuances that don’t surface in structured data
• Subtle flaws in models that go unchallenged
• Competitive shifts that require sustained focus to fully understand

These gaps are rarely obvious in the moment. But over time, they can shape decisions in ways that materially impact the business.

In trying to do more with fewer people, organizations may unintentionally narrow the lens through which they see their market.

‍

Toward a More Balanced Model

None of this is an argument for rigid silos.

In fact, the opposite is true: the most effective organizations are those where forecasting, analytics, insights, and CI are deeply integrated, informing and challenging one another. This has been a major theme of the conversations I've had and published with insights expert David Berman.

But integration does not require consolidation into a single role. For consideration: a more balanced approach may involve:

• Preserving distinct areas of expertise
• Encouraging structured collaboration across functions
• Developing leaders who can connect disciplines, even if they are not specialists in all of them

In this model, the goal is not to find a “unicorn” who does everything, but to build a system where different forms of expertise work together seamlessly.

‍

One Colleague’s Reality -- and a Broader Signal

As my colleague continues his search, she’s adapting, as many are, thinking about how to position herself across multiple domains, how to check the right boxes.

It is, as she put it in one of her emails to me, “a bit of a game.” But stepping back, it’s worth asking a more fundamental question:

In the pursuit of efficiency, are we redefining these roles in a way that strengthens decision-making; or one that quietly erodes the depth of insight that has long been their foundation?

Because in an industry where the stakes are as high as they are in pharma and health care in general, depth is not a luxury. It’s a requirement.